Compare WST & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WST | KB |
|---|---|---|
| Founded | 1923 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6B | 42.2B |
| IPO Year | 2004 | 2008 |
| Metric | WST | KB |
|---|---|---|
| Price | $346.10 | $121.38 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $325.86 | N/A |
| AVG Volume (30 Days) | ★ 411.8K | 171.2K |
| Earning Date | 04-23-2026 | 04-23-2026 |
| Dividend Yield | 0.30% | ★ 2.31% |
| EPS Growth | ★ 1.49 | N/A |
| EPS | ★ 4.07 | N/A |
| Revenue | ★ $2,886,900,000.00 | N/A |
| Revenue This Year | $6.76 | $18.22 |
| Revenue Next Year | $6.22 | $3.21 |
| P/E Ratio | $85.98 | ★ $9.90 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $223.83 | $76.31 |
| 52 Week High | $386.00 | $125.66 |
| Indicator | WST | KB |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 56.63 |
| Support Level | $346.45 | $112.10 |
| Resistance Level | $359.48 | $125.64 |
| Average True Range (ATR) | 6.83 | 1.80 |
| MACD | -0.32 | 0.02 |
| Stochastic Oscillator | 24.81 | 96.13 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.